These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7665870)

  • 1. Fibrosing cholestatic hepatitis in a renal transplant recipient associated with the hepatitis B virus precore mutant.
    Booth JC; Goldin RD; Brown JL; Karayiannis P; Thomas HC
    J Hepatol; 1995 Apr; 22(4):500-3. PubMed ID: 7665870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrosing cholestatic hepatitis in a transplant recipient with hepatitis B virus precore mutant.
    Fang JW; Tung FY; Davis GL; Dolson DJ; Van Thiel DH; Lau JY
    Gastroenterology; 1993 Sep; 105(3):901-4. PubMed ID: 8359657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation.
    Chen CH; Chen PJ; Chu JS; Yeh KH; Lai MY; Chen DS
    Gastroenterology; 1994 Nov; 107(5):1514-8. PubMed ID: 7926515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosing cholestatic hepatitis after living related-donor renal transplantation.
    Waguri N; Ichida T; Fujimaki R; Ishikawa T; Nomoto M; Asakura H; Nakamaru T; Saitoh A; Arakawa M; Saitoh K; Takahashi K
    J Gastroenterol Hepatol; 1998 Nov; 13(11):1133-7. PubMed ID: 9870801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleoside analogue therapy in fibrosing cholestatic hepatitis--a case report in an HBsAg positive renal transplant recipient.
    Brind AM; Bennett MK; Bassendine MF
    Liver; 1998 Apr; 18(2):134-9. PubMed ID: 9588773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus surface mutations associated with infection after liver transplantation.
    Hawkins AE; Gilson RJ; Gilbert N; Wreghitt TG; Gray JJ; Ahlers-de Boer I; Tedder RS; Alexander GJ
    J Hepatol; 1996 Jan; 24(1):8-14. PubMed ID: 8834018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis.
    Mason AL; Wick M; White HM; Benner KG; Lee RG; Regenstein F; Riely CA; Bain VG; Campbell C; Perrillo RP
    Gastroenterology; 1993 Jul; 105(1):237-44. PubMed ID: 8514040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damage.
    Lindh M; Horal P; Dhillon AP; Furuta Y; Norkrans G
    Hepatology; 1996 Sep; 24(3):494-501. PubMed ID: 8781313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precore mutant hepatitis B virus infection and liver disease.
    Naoumov NV; Schneider R; Grötzinger T; Jung MC; Miska S; Pape GR; Will H
    Gastroenterology; 1992 Feb; 102(2):538-43. PubMed ID: 1732124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of hepatitis B precore region in serum and liver of chronic hepatitis B virus carriers.
    López-Alcorocho JM; Moraleda G; Bartolomé J; Castillo I; Cotonat T; Aguilar J; Ortega E; Pons JA; Salmerón J; Vázquez-Iglesias JL
    J Hepatol; 1994 Sep; 21(3):353-60. PubMed ID: 7836704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea.
    Yoo BC; Park JW; Kim HJ; Lee DH; Cha YJ; Park SM
    J Hepatol; 2003 Jan; 38(1):98-103. PubMed ID: 12480566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation.
    McIvor C; Morton J; Bryant A; Cooksley WG; Durrant S; Walker N
    Ann Intern Med; 1994 Aug; 121(4):274-5. PubMed ID: 8037408
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B.
    Brunetto MR; Giarin M; Saracco G; Oliveri F; Calvo P; Capra G; Randone A; Abate ML; Manzini P; Capalbo M
    Gastroenterology; 1993 Sep; 105(3):845-50. PubMed ID: 7689519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrosing cholestatic hepatitis-like syndrome in hepatitis B virus-negative and hepatitis C virus-negative renal transplant recipients.
    Muñoz de Bustillo E; Benito A; Colina F; Andrés A; Domínguez-Gil B; Muñoz MA; Rodicio JL; Morales JM
    Am J Kidney Dis; 2001 Sep; 38(3):640-5. PubMed ID: 11532698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection.
    Chan HL; Tsang SW; Liew CT; Tse CH; Wong ML; Ching JY; Leung NW; Tam JS; Sung JJ
    Am J Gastroenterol; 2002 Feb; 97(2):406-12. PubMed ID: 11866280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
    Kim HJ; Yoo BC
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis.
    Davies SE; Portmann BC; O'Grady JG; Aldis PM; Chaggar K; Alexander GJ; Williams R
    Hepatology; 1991 Jan; 13(1):150-7. PubMed ID: 1988336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of wild-type and precore mutant HBV infection after liver transplantation.
    Torre F; Wong PY; Macartney M; Williams R; Naoumov NV
    J Med Virol; 1999 Sep; 59(1):5-13. PubMed ID: 10440801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of hepatitis B virus precore mutant in hepatitis type B.
    Ichikawa T; Takagi H; Kinoshita M; Shimoda R; Nagamine T; Mori M
    Tohoku J Exp Med; 1998 Dec; 186(4):323-33. PubMed ID: 10328164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation.
    Angus PW; Locarnini SA; McCaughan GW; Jones RM; McMillan JS; Bowden DS
    Hepatology; 1995 Jan; 21(1):14-8. PubMed ID: 7806147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.